DCOY
Decoy Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$7.62
+0.13 ▲ +1.74%
🌙 3월 13일 7:40 PM ET (한국 3/14 08:40)
$7.51
-0.11 ▼ -1.44%
| Index | - | P/E | - | EPS (ttm) | -470.76 | Insider Own | 5.56% | Shs Outstand | 0.00B | Perf Week | 0.51% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | 77.55% | Insider Trans | - | Shs Float | 0.00B | Perf Month | -12.53% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | -6.48 | Inst Own | 1.24% | Short Float | 5.11% | Perf Quarter | -26.84% |
| Income | -0.01B | P/S | - | EPS this Y | 94.44% | Inst Trans | 1.85% | Short Ratio | 0.13 | Perf Half Y | -87.95% |
| Sales | 0.00B | P/B | 0.14 | EPS next 5Y | 73.54% | ROA | -100.54% | Short Interest | 0.03M | Perf YTD | -2.13% |
| Book/sh | 53.97 | P/C | 0.84 | EPS past 3/5Y | 54.55% 57.63% | ROE | -139.55% | 52W High | -98.17% ($415.80) | Perf Year | -95.58% |
| Cash/sh | 9.05 | P/FCF | - | Sales past 3/5Y | - | ROIC | -117.81% | 52W Low | 23.35% ($6.18) | Perf 3Y | -99.75% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 68.08% | Gross Margin | - | Volatility(W/M) | 11.3% 9.7% | Perf 5Y | -99.99% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.92 | Perf 10Y | -100% |
| Dividend Ex-Date | - | Quick Ratio | 2.79 | EPS Q/Q | 84.06% | Profit Margin | - | RSI (14) | 43.24 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.79 | Sales Q/Q | - | SMA20 | -7.68% ($8.25) | Beta | 0.31 | Target Price | $30 |
| Payout | - | Debt/Eq | 0 | Earnings | 2025/11/13 | SMA50 | -14.32% ($8.89) | Rel Volume | 0.11 | Prev Close | $7.49 |
| Employees | 2 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -86.82% ($57.81) | Avg Volume(3M) | 0.19M | Price | $7.62 |
| IPO | 2015/1/29 | Option/Short | No/Yes | Trades | 223 | Volume | 20,987 | Change | 1.74% |
뉴스 로딩 중...